Vir Biotechnology, Inc.
Vir Biotechnology, Inc. scores highest on Nitro (85) and lowest on Earnings (24). Its PosiPenta is 49.21 out of 100, around the middle of similar companies.
On the Penta Grid this week, Vir Biotechnology, Inc. is Grid #298 of 837 in the Healthcare sector in United States, and Grid #1,972 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Vir Biotechnology, Inc. | 49.21 | 31 | 24 | 85 | 57 | 50 |
| AMN Healthcare Services, Inc. | 63.92 | 64 | 49 | 98 | 52 | 56 |
| Butterfly Network, Inc. | 51.18 | 7 | 68 | 77 | 54 | 50 |
| Maze Therapeutics, Inc. | 37.46 | 20 | 21 | 47 | 52 | 47 |
| Palvella Therapeutics, Inc. | 41.85 | 8 | 13 | 76 | 50 | 62 |
| Alphatec Holdings, Inc. | 37.82 | 0 | 73 | 45 | 4 | 67 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.66 |
| P/B ratio | 1.72 |
EEarnings
| Trailing EPS | ₹-166.70 |
| Forward EPS | ₹-235.57 |
NNitro
| Price | 943.36 |
| 52-week high | 1136.58 |
| 52-week low | 456.05 |
| Fall from 52-week high | 17.0% |
TTorque
| Return on equity (ROE) | -26.08% |
| Debt-to-equity | 0.09 |
AAnchor
| Beta (price swings) | 1.59 |
| Market cap | ₹15,963 Cr |
| Insider holding | 6.57% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Vir Biotechnology, Inc.'s PosiPenta score?
Vir Biotechnology, Inc.'s PosiPenta is 49.21 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Vir Biotechnology, Inc. stand on the Penta Grid?
On the Penta Grid this week, Vir Biotechnology, Inc. is Grid #298 of 837 in the Healthcare sector in United States, and Grid #1,972 of 4,000 in United States.
Which PosiPenta pillar is strongest for Vir Biotechnology, Inc.?
Nitro (momentum), with a score of 85 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Vir Biotechnology, Inc.?
Earnings (growth), with a score of 24 out of 100: weaker than most similar companies.
Has Vir Biotechnology, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.92 points, from 44.29 to 49.21.
PositoAI is for research and education only and is not investment advice.